Table 2

Antithrombotic treatment in patients with ACS and AF and patients with ACS and without AF

With AF (n=286)Without AF (n=3326)
In-hospital
 Aspirin (n(%))280 (97.9)3291 (98.9)
 Clopidogre l(n(%))284 (99.3)3318 (99.8)
 Parenteral anticoagulants *(n(%))102 (35.7)*698 (21.0)
 OACs (n(%))85 (29.7)*8 (0.2)
 Warfarin (n(%))38 (13.3)*3 (0.1)
 NOACs (n(%))47 (16.4)*5 (0.2)
At discharge
 Aspirin (n(%))281 (98.3)3289 (98.9)
 Clopidogrel (n(%))282 (98.6)3316 (99.7)
 OACs (n(%))62 (21.7)7 (0.2)
 Warfarin (n(%))30 (10.5)3 (0.1)
 NOACs (n(%))32 (11.2)4 (0.1)
  • Categorical variables are expressed as number (percentages).

  • *P<0.01 versus ‘without AF’ group.

  • ACS, acute coronary syndrome; AF, atrial fibrillation; NOACs, non-vitamin K antagonist oral anticoagulants; OACs, oral anticoagulants.